Generation mechanisms and management strategies of adverse reactions to Bevacizumab during cancer treatment.
- Author:
Fei-jiao GE
;
Jian-ming XU
- Publication Type:Journal Article
- MeSH:
Angiogenesis Inhibitors;
adverse effects;
therapeutic use;
Angiotensin-Converting Enzyme Inhibitors;
therapeutic use;
Antibodies, Monoclonal;
adverse effects;
therapeutic use;
Antibodies, Monoclonal, Humanized;
Aspirin;
administration & dosage;
therapeutic use;
Bevacizumab;
Hemorrhage;
chemically induced;
Humans;
Hypertension;
chemically induced;
drug therapy;
Intestinal Perforation;
chemically induced;
surgery;
Neoplasms;
drug therapy;
Proteinuria;
chemically induced;
Thromboembolism;
chemically induced;
drug therapy
- From:
Chinese Journal of Oncology
2010;32(7):481-486
- CountryChina
- Language:Chinese
